CYTH Annual Total Long Term Liabilities
$22.50 K
+$22.50 K+100.00%
31 December 2023
Summary:
As of January 23, 2025, CYTH annual total long term liabilities is $22.50 thousand, with the most recent change of +$22.50 thousand (+100.00%) on December 31, 2023. During the last 3 years, it has fallen by -$40.40 thousand (-64.23%). CYTH annual total long term liabilities is now -97.17% below its all-time high of $795.50 thousand, reached on December 31, 2013.CYTH Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTH Quarterly Long Term Liabilities
$7100.00
-$5300.00-42.74%
30 September 2024
Summary:
As of January 23, 2025, CYTH quarterly total long term liabilities is $7100.00, with the most recent change of -$5300.00 (-42.74%) on September 30, 2024. Over the past year, it has dropped by -$15.40 thousand (-68.44%). CYTH quarterly long term liabilities is now -99.12% below its all-time high of $809.40 thousand, reached on September 30, 2013.CYTH Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTH Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -68.4% |
| 3 y3 years | -64.2% | -68.4% |
| 5 y5 years | +100.0% | -68.4% |
CYTH Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -80.5% | ||
| 5 y | 5-year | -64.2% | -94.3% | ||
| alltime | all time | -97.2% | -99.1% |
Cyclo Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7100.00(-42.7%) |
| June 2024 | - | $12.40 K(-29.1%) |
| Mar 2024 | - | $17.50 K(-22.2%) |
| Dec 2023 | $22.50 K(>+9900.0%) | $22.50 K(-17.6%) |
| Sept 2023 | - | $27.30 K(-14.4%) |
| June 2023 | - | $31.90 K(-12.6%) |
| Mar 2023 | - | $36.50 K(>+9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $18.00 K(-71.4%) | $18.00 K(-63.9%) |
| Sept 2021 | - | $49.90 K(-39.1%) |
| June 2021 | - | $82.00 K(-27.4%) |
| Mar 2021 | - | $112.90 K(+79.5%) |
| Dec 2020 | $62.90 K(+74.2%) | $62.90 K(-35.2%) |
| Sept 2020 | - | $97.00 K(-22.5%) |
| June 2020 | - | $125.10 K(+293.4%) |
| Mar 2020 | - | $31.80 K(-11.9%) |
| Dec 2019 | $36.10 K(>+9900.0%) | $36.10 K(-14.7%) |
| Sept 2019 | - | $42.30 K(-8.4%) |
| June 2019 | - | $46.20 K(-7.6%) |
| Mar 2019 | - | $50.00 K(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2014 | - | $749.10 K(-2.3%) |
| June 2014 | - | $767.10 K(-1.8%) |
| Mar 2014 | - | $781.20 K(-1.8%) |
| Dec 2013 | $795.50 K(+6.0%) | $795.50 K(-1.7%) |
| Sept 2013 | - | $809.40 K(+6.1%) |
| June 2013 | - | $763.20 K(+9.1%) |
| Mar 2013 | - | $699.30 K(-6.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $750.80 K(+5.3%) | $750.80 K(+2.4%) |
| Sept 2012 | - | $733.20 K(-1.6%) |
| June 2012 | - | $745.40 K(-1.6%) |
| Mar 2012 | - | $757.20 K(+6.2%) |
| Dec 2011 | $713.30 K(+67.3%) | $713.30 K(-1.1%) |
| Sept 2011 | - | $720.90 K(-1.1%) |
| June 2011 | - | $728.60 K(-0.9%) |
| Mar 2011 | - | $735.00 K(+72.4%) |
| Dec 2010 | $426.40 K(+546.1%) | $426.40 K(-0.2%) |
| Sept 2010 | - | $427.40 K(>+9900.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(-100.0%) |
| Dec 2009 | $66.00 K(>+9900.0%) | $66.00 K(>+9900.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2008 | - | $25.90 K(-83.6%) |
| Dec 2007 | $157.50 K(+10.9%) | $157.50 K(+15.1%) |
| Sept 2007 | - | $136.80 K(-1.4%) |
| June 2007 | - | $138.80 K(-1.5%) |
| Mar 2007 | - | $140.90 K(-0.8%) |
| Dec 2006 | $142.00 K(-4.5%) | $142.00 K(-1.2%) |
| Sept 2006 | - | $143.70 K(-1.1%) |
| June 2006 | - | $145.30 K(-1.1%) |
| Mar 2006 | - | $146.90 K(-1.2%) |
| Dec 2005 | $148.70 K(-20.1%) | $148.70 K(+1.2%) |
| Sept 2005 | - | $147.00 K(-1.3%) |
| June 2005 | - | $149.00 K(-12.4%) |
| Mar 2005 | - | $170.10 K(-8.6%) |
| Dec 2004 | $186.20 K(-15.7%) | $186.20 K(-22.5%) |
| Sept 2004 | - | $240.40 K(+5.0%) |
| June 2004 | - | $229.00 K(+1.3%) |
| Mar 2004 | - | $226.10 K(+2.3%) |
| Dec 2003 | $221.00 K(-15.5%) | $221.00 K(-5.2%) |
| Sept 2003 | - | $233.00 K(-6.0%) |
| June 2003 | - | $247.90 K(-1.2%) |
| Mar 2003 | - | $251.00 K(-4.0%) |
| Dec 2002 | $261.40 K(+1.6%) | $261.40 K(+2.6%) |
| Sept 2002 | - | $254.90 K(-4.8%) |
| June 2002 | - | $267.70 K(-0.9%) |
| Mar 2002 | - | $270.10 K(+5.0%) |
| Dec 2001 | $257.30 K(+8.9%) | $257.30 K(+69.2%) |
| Sept 2001 | - | $152.10 K(-1.2%) |
| June 2001 | - | $154.00 K(-10.5%) |
| Mar 2001 | - | $172.10 K(-27.2%) |
| Dec 2000 | $236.30 K | $236.30 K(+31.8%) |
| Sept 2000 | - | $179.30 K |
FAQ
- What is Cyclo Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual total long term liabilities year-on-year change?
- What is Cyclo Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly long term liabilities year-on-year change?
What is Cyclo Therapeutics annual total long term liabilities?
The current annual total long term liabilities of CYTH is $22.50 K
What is the all time high annual total long term liabilities for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual total long term liabilities is $795.50 K
What is Cyclo Therapeutics annual total long term liabilities year-on-year change?
Over the past year, CYTH annual total long term liabilities has changed by +$22.50 K (+100.00%)
What is Cyclo Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of CYTH is $7100.00
What is the all time high quarterly long term liabilities for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly total long term liabilities is $809.40 K
What is Cyclo Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, CYTH quarterly total long term liabilities has changed by -$15.40 K (-68.44%)